Today: 30 June 2026
Honeywell stock jumps after JPMorgan upgrade, with Quantinuum IPO in focus
16 January 2026
2 mins read

Honeywell stock jumps after JPMorgan upgrade, with Quantinuum IPO in focus

New York, Jan 16, 2026, 13:33 EST — Regular session in progress.

  • Honeywell shares climbed roughly 2.4% in afternoon trading following a JPMorgan upgrade
  • As the company prepares major portfolio shifts, investors are eyeing potential value unlocking
  • The next milestone: Jan. 29 results and 2026 outlook, where breakup costs will come under scrutiny

Shares of Honeywell International climbed roughly 2.4% on Friday, closing at $220.16. The industrial giant edged past its previous close as investors responded to a new bullish recommendation ahead of the company’s late-January outlook.

This move is significant as Honeywell approaches a critical phase where it must provide clearer details on its breakup strategy and outline how each segment will perform independently. The stock, long viewed as a stable industrial play, is now being valued more on the timing, structure, and expense of its planned spin-offs.

Friday’s jump came during a week when traders are busy untangling “old Honeywell” from what’s on the horizon: a leaner company focused more sharply on aerospace, automation, and advanced materials. A clearer, even cautious, outlook could quickly shift the market’s expectations.

On Friday, JPMorgan bumped Honeywell’s rating from “neutral” to “overweight” and lifted its price target to $255 from $218, according to analyst Stephen Tusa, as reported by GuruFocus.

JPMorgan, in a separate note, highlighted what it called a “discount to its sum-of-the-parts valuation”—a term bankers use when they value each business on its own. The bank argued that the underlying momentum appears stronger than the headline figures imply. It also pointed out “stranded costs” related to the breakup—expenses that won’t go away even after a unit is spun off—and said investors should get more clarity once guidance is released. Investing.com

Honeywell grabbed attention this week with news that its majority-owned quantum computing arm, Quantinuum, intends to file draft IPO documents confidentially with the U.S. securities regulator. The company didn’t reveal any details on share count or offering terms.

Quantinuum’s IPO announcement throws a new variable into the ongoing valuation debate. Quantum computing remains an early-stage technology designed to tackle specific problems more quickly than current machines, yet it has also attracted wildly volatile expectations.

Investors are eyeing Jan. 29, when Honeywell will unveil its fourth-quarter results and lay out its 2026 outlook ahead of the market open. A conference call is scheduled for 8:30 a.m. EST.

Broader markets held steady Friday, making Honeywell’s rise feel more idiosyncratic than part of a wider trend. With U.S. markets closed Monday for Martin Luther King Jr. Day, next week’s catalyst calendar is set to be tight.

Still, the situation works both ways. If breakup expenses spike or 2026 guidance gets pinched by one-off charges, the stock could take a hit despite the longer-term outlook. For Quantinuum, a weak IPO environment might push back the timeline and dull the short-term “unlock” trade.

Honeywell’s earnings report and outlook call on Jan. 29 is next. Investors will zero in on clearer segment breakdowns, updates on separation costs, and any hints about when Quantinuum’s filing could be released.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Concentrix Q2 EPS Comes In Light, Stock Down Nearly 40% for the Year
    June 29, 2026, 7:00 PM EDT. Concentrix (CNXC) posted Q2 earnings of $2.63 a share, a penny below the Zacks Consensus of $2.64. Revenue was $2.46 billion, a 0.43% miss versus estimates, but up from $2.42 billion last year. Concentrix has only topped earnings estimates once in the past four quarters. Shares have dropped about 39.9% since the start of the year, trailing the S&P 500, which is up 7.4%. CNXC has a Zacks Rank #3 (Hold) as earnings estimate revisions remain uneven. Analysts are looking for $3.18 EPS and $2.54 billion revenue next quarter; full-year revenue is forecast at $11.65 billion. The Business-Services group sits in the top 42% of Zacks sectors. Investors are focused on the company's earnings call for any update on guidance.
Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls
Previous Story

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls

Merck stock slips as FDA fast-track questions build and earnings near
Next Story

Merck stock slips as FDA fast-track questions build and earnings near

Go toTop